MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention

Recruiting
Conditions
Cardiovascular Disease
Obesity
First Posted Date
2013-08-23
Last Posted Date
2025-05-20
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
200
Registration Number
NCT01927783
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Use of Cardiac-MRI to Predict Results for People With Severe Aortic Stenosis

Withdrawn
Conditions
Aortic Valve Stenosis
First Posted Date
2013-07-23
Last Posted Date
2019-09-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT01905852

Extended Dosing With Eltrombopag for Severe Aplastic Anemia

Phase 2
Completed
Conditions
Severe Aplastic Anemia (SAA)
Interventions
First Posted Date
2013-07-03
Last Posted Date
2023-04-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
40
Registration Number
NCT01891994
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

Phase 1
Completed
Conditions
Lymphoma, Non-Hodgkin
AML (Acute Myelogenous Leukemia
Myeloproliferative Disorder
MDS (Myelodysplastic Syndrome)
ALL (Acute B-Lymphoblastic Leukemia)
Interventions
Device: Graft Manipulation (CD34+ Selection)
First Posted Date
2013-06-03
Last Posted Date
2020-07-21
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
41
Registration Number
NCT01866839
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Phase 1
Completed
Conditions
Obesity
Interventions
First Posted Date
2013-05-24
Last Posted Date
2018-09-04
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
24
Registration Number
NCT01862029
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance

Completed
Conditions
Obesity
First Posted Date
2013-05-24
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
13
Registration Number
NCT01862757
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Phase 1
Recruiting
Conditions
Lymphangioleiomyomatosis
Interventions
First Posted Date
2013-02-26
Last Posted Date
2025-05-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
100
Registration Number
NCT01799538
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol

Completed
Conditions
Sickle Cell Anemia
Interventions
First Posted Date
2013-02-05
Last Posted Date
2020-08-20
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
150
Registration Number
NCT01783990
Locations
🇺🇸

Sinai Hospital of Baltimore Alfred I Coplan Pediatric Hematology Oncology Outpatient Center, Baltimore, Maryland, United States

🇺🇸

University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

🇺🇸

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

and more 11 locations

Longitudinal Observational Study of Severe Asthma

Recruiting
Conditions
Asthma
First Posted Date
2013-01-30
Last Posted Date
2025-05-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
600
Registration Number
NCT01780142
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

Completed
Conditions
Psoriasis
Cardiovascular Disease
Inflammation
Metabolic Disease
First Posted Date
2013-01-29
Last Posted Date
2025-05-20
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
386
Registration Number
NCT01778569
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath